Identity
- Security key
- 20841
- Ticker
- RDHL
- Type
- ADRC — American Depository Receipt Common
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2013-01-07
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- RDHL
Detail
Enriched 2026-08-14 20:47
- Market cap
- $3,587,742.8
- Shares outstanding (class)
- 6,080,920
- Shares outstanding (weighted)
- 6,080,920
- SIC
- —
- Employees
- 23
- Location
- —
- Homepage
- https://www.redhillbio.com
- Description
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
Market cap and share counts drift.